The novel identification of the HLA-DQA1*03:03 allele as a unique risk factor for MAV and the protective factor of HLA-DRB1*03:01 suggests the role of a genetic predisposition in the MAV group that differs from non-MAV myositis patients. Here, HLA-DRB1 is linked to myositis disease.